BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22521342)

  • 1. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
    Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
    J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.
    Rupp C; Friedrich K; Folseraas T; Wannhoff A; Bode KA; Weiss KH; Schirmacher P; Sauer P; Stremmel W; Gotthardt DN
    Aliment Pharmacol Ther; 2014 Apr; 39(8):873-82. PubMed ID: 24612312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
    Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
    Srivastava B; Mells GF; Cordell HJ; Muriithi A; Brown M; Ellinghaus E; Franke A; ; Karlsen TH; Sandford RN; Alexander GJ; Chapman RW; Rushbrook SM; Melum E
    Scand J Gastroenterol; 2012 Jul; 47(7):820-6. PubMed ID: 22554193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
    Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
    Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis.
    Kanai S; Fujiwara H; Mizuno S; Kishikawa T; Nakatsuka T; Hamada T; Tanaka M; Arita J; Nakai Y; Isayama H; Kasuga M; Tateishi R; Tateishi K; Ushiku T; Hasegawa K; Koike K; Fujishiro M
    Dig Liver Dis; 2024 Feb; 56(2):305-311. PubMed ID: 37722959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.
    Maroni L; van de Graaf SF; Hohenester SD; Oude Elferink RP; Beuers U
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):182-91. PubMed ID: 24828903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
    Janse M; Lamberts LE; Franke L; Raychaudhuri S; Ellinghaus E; Muri Boberg K; Melum E; Folseraas T; Schrumpf E; Bergquist A; Björnsson E; Fu J; Jan Westra H; Groen HJ; Fehrmann RS; Smolonska J; van den Berg LH; Ophoff RA; Porte RJ; Weismüller TJ; Wedemeyer J; Schramm C; Sterneck M; Günther R; Braun F; Vermeire S; Henckaerts L; Wijmenga C; Ponsioen CY; Schreiber S; Karlsen TH; Franke A; Weersma RK
    Hepatology; 2011 Jun; 53(6):1977-85. PubMed ID: 21425313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association analysis in primary sclerosing cholangitis.
    Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
    Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
    Webb GJ; Hirschfield GM
    J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12.
    Kurreeman FA; Stahl EA; Okada Y; Liao K; Diogo D; Raychaudhuri S; Freudenberg J; Kochi Y; Patsopoulos NA; Gupta N; ; Sandor C; Bang SY; Lee HS; Padyukov L; Suzuki A; Siminovitch K; Worthington J; Gregersen PK; Hughes LB; Reynolds RJ; Bridges SL; Bae SC; Yamamoto K; Plenge RM
    Am J Hum Genet; 2012 Mar; 90(3):524-32. PubMed ID: 22365150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
    Liu JZ; Hov JR; Folseraas T; Ellinghaus E; Rushbrook SM; Doncheva NT; Andreassen OA; Weersma RK; Weismüller TJ; Eksteen B; Invernizzi P; Hirschfield GM; Gotthardt DN; Pares A; Ellinghaus D; Shah T; Juran BD; Milkiewicz P; Rust C; Schramm C; Müller T; Srivastava B; Dalekos G; Nöthen MM; Herms S; Winkelmann J; Mitrovic M; Braun F; Ponsioen CY; Croucher PJ; Sterneck M; Teufel A; Mason AL; Saarela J; Leppa V; Dorfman R; Alvaro D; Floreani A; Onengut-Gumuscu S; Rich SS; Thompson WK; Schork AJ; Næss S; Thomsen I; Mayr G; König IR; Hveem K; Cleynen I; Gutierrez-Achury J; Ricaño-Ponce I; van Heel D; Björnsson E; Sandford RN; Durie PR; Melum E; Vatn MH; Silverberg MS; Duerr RH; Padyukov L; Brand S; Sans M; Annese V; Achkar JP; Boberg KM; Marschall HU; Chazouillères O; Bowlus CL; Wijmenga C; Schrumpf E; Vermeire S; Albrecht M; ; Rioux JD; Alexander G; Bergquist A; Cho J; Schreiber S; Manns MP; Färkkilä M; Dale AM; Chapman RW; Lazaridis KN; ; Franke A; Anderson CA; Karlsen TH;
    Nat Genet; 2013 Jun; 45(6):670-5. PubMed ID: 23603763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.
    McGovern DP; Jones MR; Taylor KD; Marciante K; Yan X; Dubinsky M; Ippoliti A; Vasiliauskas E; Berel D; Derkowski C; Dutridge D; Fleshner P; Shih DQ; Melmed G; Mengesha E; King L; Pressman S; Haritunians T; Guo X; Targan SR; Rotter JI;
    Hum Mol Genet; 2010 Sep; 19(17):3468-76. PubMed ID: 20570966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
    Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
    Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
    Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
    Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on primary sclerosing cholangitis genetics.
    Henriksen EK; Melum E; Karlsen TH
    Curr Opin Gastroenterol; 2014 May; 30(3):310-9. PubMed ID: 24565892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction analysis between BLK rs13277113 polymorphism and BANK1 rs3733197 polymorphism, MMEL1/TNFRSF14 rs3890745 polymorphism in determining susceptibility to rheumatoid arthritis.
    Huang H; Huang SC; Hua DJ; Sun QQ; Cen H; Xin XF
    Autoimmunity; 2017 Nov; 50(7):403-408. PubMed ID: 28925718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
    Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
    Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.